2025
SJR Q4
JCR Q1 · 5
7 matched articles
SCIE
Journal detail
HLA
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
2059230220592310
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,273
- Quartile Q4
- H-Index 110
- Cites/doc 0,88
- Docs (3y) 1.303
- Cites (3y) 938
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5
- 5Y JIF 3,8
- JCI 0,63
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Genetics Q4
- Immunology Q4
- Immunology and Allergy Q4
Areas
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
- Medicine
WoS categories
- Cell Biology | Immunology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q4 | Q1 | 0,273 | 5 | 3,8 | 0,63 | Q3 | 110 |
| 2024 | Q4 | Q1 | 0,214 | 4,9 | 3,7 | 0,67 | Q3 | 108 |
| 2023 | Q4 | Q1 | 0,305 | 6,5 | 3,8 | 0,76 | Q2 | 108 |
| 2022 | Q4 | Q1 | 0,307 | 8 | 4,3 | 0,72 | Q2 | 108 |
| 2021 | Q3 | Q1 | 0,405 | 9,2 | 5,3 | 0,65 | Q3 | 108 |
| 2020 | Q4 | Q1 | 0,347 | 4,5 | 3,8 | 0,53 | Q3 | 108 |
| 2019 | Q3 | Q2 | 0,35 | 3 | 3 | 0,65 | Q3 | 108 |
| 2018 | — | Q2 | — | 2,8 | 2,8 | 0,69 | Q3 | — |
| 2017 | Q3 | Q2 | 0,438 | 2,6 | 2,6 | 0,68 | Q2 | 108 |
| 2016 | Q3 | — | 0,467 | — | — | — | — | 108 |
| 2015 | Q3 | — | 0,763 | — | — | — | — | 108 |
| 2014 | Q3 | — | 0,678 | — | — | — | — | 108 |
| 2013 | Q2 | — | 1,001 | — | — | — | — | 108 |
| 2012 | Q3 | — | 0,675 | — | — | — | — | 108 |
| 2011 | Q2 | — | 0,757 | — | — | — | — | 108 |
| 2010 | Q3 | — | 0,605 | — | — | — | — | 108 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q3 | 76/207 |
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q3 | 52/183 |
| 2025 | PATHOLOGY | SCIE | Q1 | Q3 | 7/89 |
| 2024 | CELL BIOLOGY | SCIE | Q2 | Q3 | 65/204 |
| 2024 | IMMUNOLOGY | SCIE | Q2 | Q3 | 46/183 |
| 2024 | PATHOLOGY | SCIE | Q1 | Q3 | 8/90 |
| 2023 | CELL BIOLOGY | SCIE | Q1 | Q2 | 43/205 |
| 2023 | IMMUNOLOGY | SCIE | Q1 | Q2 | 31/181 |
| 2023 | PATHOLOGY | SCIE | Q1 | Q2 | 6/88 |
| 2022 | CELL BIOLOGY | SCIE | Q1 | Q2 | 36/191 |
| 2022 | IMMUNOLOGY | SCIE | Q1 | Q2 | 29/161 |
| 2022 | PATHOLOGY | SCIE | Q1 | Q2 | 4/76 |
| 2021 | CELL BIOLOGY | SCIE | Q1 | Q3 | 40/195 |
| 2021 | IMMUNOLOGY | SCIE | Q1 | Q3 | 33/162 |
| 2021 | PATHOLOGY | SCIE | Q1 | Q3 | 5/77 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q3 | 98/195 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q3 | 71/162 |
| 2020 | PATHOLOGY | SCIE | Q1 | Q3 | 19/77 |
| 2019 | CELL BIOLOGY | SCIE | Q3 | Q3 | 124/195 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 96/159 |
| 2019 | PATHOLOGY | SCIE | Q2 | Q3 | 22/78 |
| 2018 | CELL BIOLOGY | SCIE | Q3 | Q3 | 126/193 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q3 | 99/158 |
| 2018 | PATHOLOGY | SCIE | Q2 | Q3 | 25/76 |
| 2017 | CELL BIOLOGY | SCIE | Q3 | Q3 | 127/190 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q3 | 100/155 |
| 2017 | PATHOLOGY | SCIE | Q2 | Q2 | 27/79 |
| 2016 | CELL BIOLOGY | SCIE | — | — | — |
| 2016 | IMMUNOLOGY | SCIE | — | — | — |
| 2016 | PATHOLOGY | SCIE | — | — | — |